Literature DB >> 20708797

Changes in the metabolic footprint of placental explant-conditioned medium cultured in different oxygen tensions from placentas of small for gestational age and normal pregnancies.

R P Horgan1, D I Broadhurst, W B Dunn, M Brown, A E P Heazell, D B Kell, P N Baker, L C Kenny.   

Abstract

Being born small for gestational age (SGA) confers significantly increased risks of perinatal morbidity and mortality. Accumulating evidence suggests that an SGA fetus results from a poorly perfused and abnormally developed placenta. Some of the placental features seen in SGA, such as abnormal cell turnover and impaired nutrient transport, can be reproduced by culture of placental explants in hypoxic conditions. Metabolic footprinting offers a hypothesis-generating strategy to investigate factors absorbed by and released from this tissue in vitro. Previously, metabolic footprinting of the conditioned culture media has identified differences in placental explants cultured under normoxic and hypoxic conditions and between normal pregnancies and those complicated by pre-eclampsia. In this study we aimed to examine the differences in the metabolic footprint of placental villous explants cultured at different oxygen (O(2)) tensions between women who deliver an SGA baby (n = 9) and those from normal controls (n = 8). Placental villous explants from cases and controls were cultured for 96 h in 1% (hypoxic), 6% (normoxic) and 20% (hyperoxic) O(2). Metabolic footprints were analysed by Ultra Performance Liquid Chromatography coupled to an electrospray hybrid LTQ-Orbitrap Mass Spectrometry (UPLC-MS). 574 metabolite features showed significant difference between SGA and normal at one or more of the oxygen tensions. SGA explant media cultured under hypoxic conditions was observed, on a univariate level, to exhibit the same metabolic signature as controls cultured under normoxic conditions in 49% of the metabolites of interest, suggesting that SGA tissue is acclimatised to hypoxic conditions in vivo. No such behaviour was observed under hyperoxic culture conditions. Glycerophospholipid and tryptophan metabolism were highlighted as areas of particular interest.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20708797     DOI: 10.1016/j.placenta.2010.07.002

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  17 in total

Review 1.  Metabolomics in the developmental origins of obesity and its cardiometabolic consequences.

Authors:  M F Hivert; W Perng; S M Watkins; C S Newgard; L C Kenny; B S Kristal; M E Patti; E Isganaitis; D L DeMeo; E Oken; M W Gillman
Journal:  J Dev Orig Health Dis       Date:  2015-01-29       Impact factor: 2.401

Review 2.  Characterizing the lipid and metabolite changes associated with placental function and pregnancy complications using ion mobility spectrometry-mass spectrometry and mass spectrometry imaging.

Authors:  Kristin E Burnum-Johnson; Erin S Baker; Thomas O Metz
Journal:  Placenta       Date:  2017-03-29       Impact factor: 3.481

3.  Metabolomic profiling of intrauterine growth-restricted preterm infants: a matched case-control study.

Authors:  Elena Priante; Giovanna Verlato; Matteo Stocchero; Giuseppe Giordano; Paola Pirillo; Luca Bonadies; Silvia Visentin; Laura Moschino; Eugenio Baraldi
Journal:  Pediatr Res       Date:  2022-09-09       Impact factor: 3.953

4.  Metabolomic profile of umbilical cord blood plasma from early and late intrauterine growth restricted (IUGR) neonates with and without signs of brain vasodilation.

Authors:  Magdalena Sanz-Cortés; Rodrigo J Carbajo; Fatima Crispi; Francesc Figueras; Antonio Pineda-Lucena; Eduard Gratacós
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

5.  Maternal Early Pregnancy Serum Metabolomics Profile and Abnormal Vaginal Bleeding as Predictors of Placental Abruption: A Prospective Study.

Authors:  Bizu Gelaye; Susan J Sumner; Susan McRitchie; James E Carlson; Cande V Ananth; Daniel A Enquobahrie; Chunfang Qiu; Tanya K Sorensen; Michelle A Williams
Journal:  PLoS One       Date:  2016-06-14       Impact factor: 3.240

6.  Exploring the Role of Different Neonatal Nutrition Regimens during the First Week of Life by Urinary GC-MS Metabolomics.

Authors:  Angelica Dessì; Antonio Murgia; Rocco Agostino; Maria Grazia Pattumelli; Andrea Schirru; Paola Scano; Vassilios Fanos; Pierluigi Caboni
Journal:  Int J Mol Sci       Date:  2016-02-22       Impact factor: 5.923

7.  Metabolites involved in glycolysis and amino acid metabolism are altered in short children born small for gestational age.

Authors:  Philip G Murray; Imogen Butcher; Warwick B Dunn; Adam Stevens; Reena Perchard; Daniel Hanson; Andrew Whatmore; Melissa Westwood; Peter E Clayton
Journal:  Pediatr Res       Date:  2016-04-08       Impact factor: 3.756

8.  Maternal urinary metabolic signatures of fetal growth and associated clinical and environmental factors in the INMA study.

Authors:  Léa Maitre; Cristina M Villanueva; Matthew R Lewis; Jesús Ibarluzea; Loreto Santa-Marina; Martine Vrijheid; Jordi Sunyer; Muireann Coen; Mireille B Toledano
Journal:  BMC Med       Date:  2016-11-04       Impact factor: 8.775

9.  Novel use of proton magnetic resonance spectroscopy (1HMRS) to non-invasively assess placental metabolism.

Authors:  Fiona C Denison; Scott I Semple; Sarah J Stock; Jane Walker; Ian Marshall; Jane E Norman
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

Review 10.  Metabolomics application in maternal-fetal medicine.

Authors:  Vassilios Fanos; Luigi Atzori; Karina Makarenko; Gian Benedetto Melis; Enrico Ferrazzi
Journal:  Biomed Res Int       Date:  2013-06-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.